Logo image of AEMD

AETHLON MEDICAL INC (AEMD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AEMD - US00808Y5050 - Common Stock

4.44 USD
+0.13 (+3.02%)
Last: 11/28/2025, 8:11:47 PM
4.2301 USD
-0.21 (-4.73%)
After Hours: 11/28/2025, 8:11:47 PM
Fundamental Rating

2

AEMD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of AEMD is average, but there are quite some concerns on its profitability. AEMD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AEMD had negative earnings in the past year.
AEMD had a negative operating cash flow in the past year.
In the past 5 years AEMD always reported negative net income.
In the past 5 years AEMD always reported negative operating cash flow.
AEMD Yearly Net Income VS EBIT VS OCF VS FCFAEMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -237.06%, AEMD is doing worse than 92.55% of the companies in the same industry.
Looking at the Return On Equity, with a value of -367.42%, AEMD is doing worse than 78.72% of the companies in the same industry.
Industry RankSector Rank
ROA -237.06%
ROE -367.42%
ROIC N/A
ROA(3y)-131.15%
ROA(5y)-104.21%
ROE(3y)-181.8%
ROE(5y)-137.98%
ROIC(3y)N/A
ROIC(5y)N/A
AEMD Yearly ROA, ROE, ROICAEMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AEMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AEMD Yearly Profit, Operating, Gross MarginsAEMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

6

2. Health

2.1 Basic Checks

AEMD has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AEMD has been increased compared to 5 years ago.
AEMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AEMD Yearly Shares OutstandingAEMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50K 100K 150K 200K 250K
AEMD Yearly Total Debt VS Total AssetsAEMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

AEMD has an Altman-Z score of -48.48. This is a bad value and indicates that AEMD is not financially healthy and even has some risk of bankruptcy.
AEMD has a worse Altman-Z score (-48.48) than 93.09% of its industry peers.
AEMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -48.48
ROIC/WACCN/A
WACCN/A
AEMD Yearly LT Debt VS Equity VS FCFAEMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M 15M

2.3 Liquidity

A Current Ratio of 2.49 indicates that AEMD has no problem at all paying its short term obligations.
With a Current ratio value of 2.49, AEMD perfoms like the industry average, outperforming 49.47% of the companies in the same industry.
A Quick Ratio of 2.49 indicates that AEMD has no problem at all paying its short term obligations.
The Quick ratio of AEMD (2.49) is better than 60.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 2.49
AEMD Yearly Current Assets VS Current LiabilitesAEMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

AEMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -312.15%.
EPS 1Y (TTM)-312.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AEMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.41% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y83.4%
EPS Next 2Y38.9%
EPS Next 3Y24.75%
EPS Next 5Y14.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AEMD Yearly Revenue VS EstimatesAEMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2030 2031 2032 10M 20M 30M
AEMD Yearly EPS VS EstimatesAEMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -500 -1K -1.5K -2K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AEMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AEMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AEMD Price Earnings VS Forward Price EarningsAEMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AEMD Per share dataAEMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80

4.3 Compensation for Growth

AEMD's earnings are expected to grow with 24.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.9%
EPS Next 3Y24.75%

More info and screens

0

5. Dividend

5.1 Amount

AEMD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AETHLON MEDICAL INC

NASDAQ:AEMD (11/28/2025, 8:11:47 PM)

After market: 4.2301 -0.21 (-4.73%)

4.44

+0.13 (+3.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)02-10 2026-02-10
Inst Owners5.44%
Inst Owner Change23.71%
Ins Owners0.19%
Ins Owner Change-1.2%
Market Cap3.37M
Revenue(TTM)N/A
Net Income(TTM)-12.58M
Analysts45.71
Price Target12.62 (184.23%)
Short Float %N/A
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-335.27%
Min EPS beat(2)-673.64%
Max EPS beat(2)3.1%
EPS beat(4)2
Avg EPS beat(4)-157.71%
Min EPS beat(4)-673.64%
Max EPS beat(4)40.26%
EPS beat(8)4
Avg EPS beat(8)-75.48%
EPS beat(12)6
Avg EPS beat(12)-51.16%
EPS beat(16)8
Avg EPS beat(16)-42.9%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)309.09%
PT rev (3m)309.09%
EPS NQ rev (1m)29.55%
EPS NQ rev (3m)-613.64%
EPS NY rev (1m)33.14%
EPS NY rev (3m)-633.57%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)-92.98
EYN/A
EPS(NY)-6.02
Fwd EYN/A
FCF(TTM)-10.01
FCFYN/A
OCF(TTM)-10.01
OCFYN/A
SpS0
BVpS4.5
TBVpS4.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -237.06%
ROE -367.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-131.15%
ROA(5y)-104.21%
ROE(3y)-181.8%
ROE(5y)-137.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 2.49
Altman-Z -48.48
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)153.85%
Cap/Depr(5y)180.64%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-312.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.75%
EPS Next Y83.4%
EPS Next 2Y38.9%
EPS Next 3Y24.75%
EPS Next 5Y14.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.82%
OCF growth 3YN/A
OCF growth 5YN/A

AETHLON MEDICAL INC / AEMD FAQ

Can you provide the ChartMill fundamental rating for AETHLON MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to AEMD.


What is the valuation status of AETHLON MEDICAL INC (AEMD) stock?

ChartMill assigns a valuation rating of 1 / 10 to AETHLON MEDICAL INC (AEMD). This can be considered as Overvalued.


Can you provide the profitability details for AETHLON MEDICAL INC?

AETHLON MEDICAL INC (AEMD) has a profitability rating of 0 / 10.


How financially healthy is AETHLON MEDICAL INC?

The financial health rating of AETHLON MEDICAL INC (AEMD) is 6 / 10.